Detalles de la búsqueda
1.
Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
BMC Neurol
; 22(1): 205, 2022 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-35659622
2.
Patient preference for early onset of efficacy of preventive migraine treatments.
Headache
; 62(3): 374-382, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35187644
3.
Erenumab dosage for migraine prevention: An evidence-based narrative review with recommendations.
Headache
; 62(4): 420-435, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35137404
4.
Early response to eptinezumab indicates high likelihood of continued response in patients with chronic migraine.
J Headache Pain
; 23(1): 29, 2022 Feb 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35189811
5.
Eptinezumab treatment initiated during a migraine attack is associated with meaningful improvement in patient-reported outcome measures: secondary results from the randomized controlled RELIEF study.
J Headache Pain
; 23(1): 22, 2022 Feb 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35130832
6.
STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD® ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients.
Headache
; 61(8): 1214-1226, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34363701
7.
Effects of Intravenous Eptinezumab vs Placebo on Headache Pain and Most Bothersome Symptom When Initiated During a Migraine Attack: A Randomized Clinical Trial.
JAMA
; 325(23): 2348-2356, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-34128999
8.
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
Cephalalgia
; 40(6): 543-553, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-32216456
9.
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response.
Cephalalgia
; 40(1): 28-38, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31816249
10.
A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine.
Headache
; 60(3): 564-575, 2020 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32037549
11.
Early Onset of Efficacy With Fremanezumab for the Preventive Treatment of Chronic Migraine.
Headache
; 59(10): 1743-1752, 2019 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-31675102
12.
Correction: Rapid resolution of migraine symptoms after initiating the preventive treatment eptinezumab during a migraine attack: results from the randomized RELIEF trial.
BMC Neurol
; 23(1): 318, 2023 Sep 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-37674117
13.
Early Onset of Efficacy and Consistency of Response Across Multiple Migraine Attacks From the Randomized COMPASS Study: AVP-825 Breath Powered® Exhalation Delivery System (Sumatriptan Nasal Powder) vs Oral Sumatriptan.
Headache
; 57(6): 862-876, 2017 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-28497569
14.
Efficacy and tolerability of zolmitriptan nasal spray for the treatment of acute migraine in adolescents: Results of a randomized, double-blind, multi-center, parallel-group study (TEENZ).
Headache
; 56(7): 1107-19, 2016 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-27329280
15.
A Phase I, Open-Label, Single-Dose Safety, Pharmacokinetic, and Tolerability Study of the Sumatriptan Iontophoretic Transdermal System in Adolescent Migraine Patients.
Headache
; 56(8): 1300-9, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27474357
16.
Consistency of response to sumatriptan/naproxen sodium in a randomized placebo-controlled, cross-over study for the acute treatment of migraine in adolescence.
Headache
; 55(4): 519-28, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25881677
17.
Migraine-related symptoms in childhood.
Curr Pain Headache Rep
; 17(8): 339, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23961555
18.
Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
Headache
; 52(8): 1219-25, 2012 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-22607530
19.
Pharmacokinetics and tolerability of rizatriptan in pediatric migraineurs in a randomized study.
Headache
; 52(4): 625-35, 2012 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-22289113
20.
Rizatriptan for treatment of acute migraine in patients taking topiramate for migraine prophylaxis.
Headache
; 52(1): 57-67, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-22078129